What is the latest CIPLA stock price?
The latest stored price for CIPLA is Rs 1,394.50 as of 2026-11-16.
CIPLA LTD is a large-cap stock in Healthcare. This Gimli page shows the latest available CIPLA price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for CIPLA is Rs 1,394.50 as of 2026-11-16.
CIPLA is above 50DMA, above 200DMA. The latest 50DMA is 1,366.23 and the latest 200DMA is 1,363.89.
CIPLA has PE 39.47, ROE +8.80%, and ROCE +11.73% in Gimli's latest available snapshot.
CIPLA has returned +5.24% over 1 month, -3.83% over 3 months, and -8.98% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 7,368.15 cr | 1,538.94 cr | 877.54 cr | 10.86 |
| 2026-06-30 | 7,077.02 cr | 1,403.20 cr | 789.05 cr | 9.77 |
| 2026-03-31 | 6,464.26 cr | 1,103.11 cr | 554.64 cr | 6.87 |
| 2025-12-31 | 6,962.97 cr | 1,185.49 cr | 675.80 cr | 8.37 |
| 2025-09-30 | 7,858.00 cr | 2,164.00 cr | 1,353.00 cr | nan |
| 2025-06-30 | 6,837.04 cr | 2,036.70 cr | 1,297.62 cr | 16.07 |
| 2025-03-31 | 6,597.72 cr | 1,827.05 cr | 1,221.84 cr | 15.13 |
| 2024-12-31 | 6,961.60 cr | 2,210.53 cr | 1,570.51 cr | 19.45 |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 27,711.69 cr | 6,355.48 cr | 3,879.23 cr | 48.03 |
| 2025-03-31 | 27,145.40 cr | 7,860.28 cr | 5,272.52 cr | 65.29 |
| 2024-03-31 | 25,446.63 cr | 6,824.05 cr | 4,121.55 cr | 51.05 |
| 2023-03-31 | 22,473.18 cr | 5,152.10 cr | 2,801.91 cr | 34.72 |
| 2022-03-31 | 16,047.52 cr | 4,588.20 cr | 2,882.58 cr | 31.20 |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 42,495.98 cr | 1,018.22 cr | 613.77 cr | 34,520.24 cr |
| 2025-03-31 | 37,387.04 cr | 588.69 cr | 438.19 cr | 31,289.25 cr |
| 2024-03-31 | 32,717.82 cr | 640.07 cr | 559.41 cr | 26,802.33 cr |
| 2023-03-31 | 29,463.28 cr | 627.63 cr | 803.12 cr | 23,713.54 cr |
| 2022-03-31 | 27,101.12 cr | 677.74 cr | 1,055.78 cr | 21,117.38 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 3,940.02 cr | 860.71 cr | n/a |
| 2025-03-31 | 5,004.98 cr | 3,456.78 cr | n/a |
| 2024-03-31 | 4,133.91 cr | 2,784.61 cr | n/a |
| 2023-03-31 | 3,237.65 cr | 2,054.76 cr | n/a |
| 2022-03-31 | 3,325.90 cr | 2,624.75 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +29.21% | +20.25% | +34.94% | +20.78% | +15.60% | +0.00% |
| 2026-06-30 | +29.21% | +20.21% | +34.63% | +20.56% | +15.94% | +0.00% |
| 2026-03-31 | +29.21% | +22.56% | +31.97% | +18.66% | +16.25% | +0.00% |
| 2025-12-31 | +29.21% | +23.93% | +30.72% | +19.21% | +16.13% | +0.00% |
| 2025-09-30 | +29.21% | +24.55% | +30.25% | +20.23% | +15.99% | +0.00% |
| 2025-06-30 | +29.19% | +25.25% | +29.26% | +20.44% | +16.30% | +0.00% |
| 2025-03-31 | +29.20% | +26.28% | +28.15% | +20.51% | +16.37% | +0.00% |
| 2024-12-31 | +29.19% | +26.65% | +27.71% | +20.46% | +16.44% | +0.00% |
| 2024-09-30 | +30.92% | +28.80% | +24.16% | +17.48% | +16.11% | +0.00% |
| 2024-06-30 | +30.91% | +27.81% | +24.95% | +17.62% | +16.33% | +0.00% |
| 2024-03-31 | +33.47% | +25.83% | +24.42% | +16.83% | +16.28% | +0.00% |
| 2023-12-31 | +33.47% | +25.73% | +24.33% | +16.66% | +16.46% | +0.00% |
| 2023-09-30 | +33.47% | +25.74% | +24.18% | +16.48% | +16.60% | +0.00% |
| 2023-06-30 | +33.47% | +25.49% | +24.33% | +15.35% | +16.69% | n/a |
| 2023-03-31 | +33.55% | +27.42% | +22.10% | +15.00% | +16.94% | +0.00% |
| 2022-12-31 | +33.61% | +28.39% | +21.13% | +14.09% | +16.87% | +0.00% |
| 2022-09-30 | +33.61% | +27.69% | +21.73% | +13.78% | +16.97% | +0.00% |
| 2022-06-30 | +33.61% | +0.00% | +48.98% | n/a | n/a | +0.00% |
| 2022-03-31 | +33.63% | +0.00% | +48.64% | n/a | n/a | +0.00% |
| 2021-12-31 | +36.11% | +0.00% | +45.88% | n/a | n/a | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| MANKIND | MANKIND PHARMA LIMITED | 108,433.48 cr | 47.905015 | +14.41% | +15.86% |
Data snapshot: 2026-11-16. Not investment advice.